Michael Nassif MD
Adult Congenital Heart Disease, Heart Failure & Transplantation
Heart Failure/Transplant Saint Luke's Mid America Heart Institute, Assistant Professor in the Department of Medicine at the University of Missouri-Kansas City (UMKC) School of Medicine
Join to view full profile
4401 WornallKansas City, MO 64111
Phone+1 816-932-2000
Dr. Nassif is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2013 - 2016- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2009 - 2012
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2009
Certifications & Licensure
KS State Medical License 2018 - 2027
MO State Medical License 2011 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM.Fernando Dominguez, Roberto Barriales-Villa, Brian L Claggett, Anne Dybro, Junbo Ge
JACC. Heart Failure. 2026-08-29 - Long-Term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM.Shepard D Weiner, Lusha W Liang, Ahmad Masri, Theodore P Abraham, Roberto Barriales-Villa
European Journal of Heart Failure. 2026-08-03 - 1 citationsExercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.Gregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, Bela Merkely, Michael E Nassif
JAMA Cardiology. 2026-08-01
Press Mentions
MAPLE-HCM: Treatment Benefit of Aficamten in Patients with Obstructive HCMNovember 8th, 2025- Health Systems Scramble to Discharge Hospital-at-Home PatientsOctober 1st, 2025
- Why Saint Luke's Plans to Expand Hospital at HomeJanuary 17th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: